Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients
ABSTRACT Background Sustained molecular detection of SARS-CoV-2 RNA in the upper respiratory tract (URT) in mild to moderate COVID-19 is common. We sought to identify host and immune determinants of prolonged SARS-CoV-2 RNA detection.Methods Ninety-five outpatients self-collected mid-turbinate nasal, oropharyngeal (OP), and gingival crevicular fluid (oral fluid) samples at home and in a research clinic a median of 6 times over 1-3 months. Samples were tested for viral RNA, virus culture, and SARS-CoV-2 and other human coronavirus antibodies, and associations were estimated using Cox proportional hazards models.Results Viral RNA clearance, as measured by SARS-CoV-2 RT-PCR, in 507 URT samples occurred a median (IQR) 33.5 (17-63.5) days post-symptom onset. Sixteen nasal-OP samples collected 2-11 days post-symptom onset were virus culture positive out of 183 RT-PCR positive samples tested. All participants but one with positive virus culture were negative for concomitant oral fluid anti-SARS-CoV-2 antibodies. The mean time to first antibody detection in oral fluid was 8-13 days post-symptom onset. A longer time to first detection of oral fluid anti-SARS-CoV-2 S antibodies (aHR 0.96, 95% CI 0.92-0.99, p=0.020) and BMI ≥ 25kg/m2 (aHR 0.37, 95% CI 0.18-0.78, p=0.009) were independently associated with a longer time to SARS-CoV-2 viral RNA clearance. Fever as one of first three COVID-19 symptoms correlated with shorter time to viral RNA clearance (aHR 2.06, 95% CI 1.02-4.18, p=0.044).Conclusions We demonstrate that delayed rise of oral fluid SARS-CoV-2-specific antibodies, elevated BMI, and absence of early fever are independently associated with delayed URT viral RNA clearance..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 15. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| doi: |
10.1101/2021.03.02.21252420 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI020068484 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI020068484 | ||
| 003 | DE-627 | ||
| 005 | 20230429083907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210305s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.03.02.21252420 |2 doi | |
| 035 | |a (DE-627)XBI020068484 | ||
| 035 | |a (biorXiv)10.1101/2021.03.02.21252420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Antar, Annukka A. R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Background Sustained molecular detection of SARS-CoV-2 RNA in the upper respiratory tract (URT) in mild to moderate COVID-19 is common. We sought to identify host and immune determinants of prolonged SARS-CoV-2 RNA detection.Methods Ninety-five outpatients self-collected mid-turbinate nasal, oropharyngeal (OP), and gingival crevicular fluid (oral fluid) samples at home and in a research clinic a median of 6 times over 1-3 months. Samples were tested for viral RNA, virus culture, and SARS-CoV-2 and other human coronavirus antibodies, and associations were estimated using Cox proportional hazards models.Results Viral RNA clearance, as measured by SARS-CoV-2 RT-PCR, in 507 URT samples occurred a median (IQR) 33.5 (17-63.5) days post-symptom onset. Sixteen nasal-OP samples collected 2-11 days post-symptom onset were virus culture positive out of 183 RT-PCR positive samples tested. All participants but one with positive virus culture were negative for concomitant oral fluid anti-SARS-CoV-2 antibodies. The mean time to first antibody detection in oral fluid was 8-13 days post-symptom onset. A longer time to first detection of oral fluid anti-SARS-CoV-2 S antibodies (aHR 0.96, 95% CI 0.92-0.99, p=0.020) and BMI ≥ 25kg/m2 (aHR 0.37, 95% CI 0.18-0.78, p=0.009) were independently associated with a longer time to SARS-CoV-2 viral RNA clearance. Fever as one of first three COVID-19 symptoms correlated with shorter time to viral RNA clearance (aHR 2.06, 95% CI 1.02-4.18, p=0.044).Conclusions We demonstrate that delayed rise of oral fluid SARS-CoV-2-specific antibodies, elevated BMI, and absence of early fever are independently associated with delayed URT viral RNA clearance. | ||
| 700 | 1 | |a Yu, Tong |e verfasserin |4 aut | |
| 700 | 1 | |a Pisanic, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Azamfirei, Razvan |e verfasserin |4 aut | |
| 700 | 1 | |a Tornheim, Jeffrey A. |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Diane M. |e verfasserin |4 aut | |
| 700 | 1 | |a Kruczynski, Kate |e verfasserin |4 aut | |
| 700 | 1 | |a Hardick, Justin P. |e verfasserin |4 aut | |
| 700 | 1 | |a Sewell, Thelio |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Minyoung |e verfasserin |4 aut | |
| 700 | 1 | |a Church, Taylor |e verfasserin |4 aut | |
| 700 | 1 | |a Walch, Samantha N. |e verfasserin |4 aut | |
| 700 | 1 | |a Reuland, Carolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Bachu, Vismaya S. |e verfasserin |4 aut | |
| 700 | 1 | |a Littlefield, Kirsten |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Han-Sol |e verfasserin |4 aut | |
| 700 | 1 | |a Ursin, Rebecca L. |e verfasserin |4 aut | |
| 700 | 1 | |a Ganesan, Abhinaya |e verfasserin |4 aut | |
| 700 | 1 | |a Kusemiju, Oyinkansola |e verfasserin |4 aut | |
| 700 | 1 | |a Barnaba, Brittany |e verfasserin |4 aut | |
| 700 | 1 | |a Charles, Curtisha |e verfasserin |4 aut | |
| 700 | 1 | |a Prizzi, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Johnstone, Jaylynn R. |e verfasserin |4 aut | |
| 700 | 1 | |a Payton, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Dai, Weiwei |e verfasserin |4 aut | |
| 700 | 1 | |a Fuchs, Joelle |e verfasserin |4 aut | |
| 700 | 1 | |a Massaccesi, Guido |e verfasserin |4 aut | |
| 700 | 1 | |a Armstrong, Derek T. |e verfasserin |4 aut | |
| 700 | 1 | |a Townsend, Jennifer L. |e verfasserin |4 aut | |
| 700 | 1 | |a Keller, Sara C. |e verfasserin |4 aut | |
| 700 | 1 | |a Demko, Zoe O |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Mei-Cheng |e verfasserin |4 aut | |
| 700 | 1 | |a Sauer, Lauren M. |e verfasserin |4 aut | |
| 700 | 1 | |a Mostafa, Heba H. |e verfasserin |4 aut | |
| 700 | 1 | |a Keruly, Jeanne C. |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Shruti H. |e verfasserin |4 aut | |
| 700 | 1 | |a Klein, Sabra L. |e verfasserin |4 aut | |
| 700 | 1 | |a Cox, Andrea L. |e verfasserin |4 aut | |
| 700 | 1 | |a Pekosz, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Heaney, Christopher D. |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, David L. |e verfasserin |4 aut | |
| 700 | 1 | |a Blair, Paul W. |e verfasserin |4 aut | |
| 700 | 1 | |a Manabe, Yukari C. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 15. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:15 |g month:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1093/ofid/ofab195 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.03.02.21252420 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 15 |c 12 | ||
| 953 | |2 045F |a 570 | ||